Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione

Authors:
Source:
GB 1397267

16.alpha.,-17-Epoxypregnane-3,11,20-trione was ketalized with HOCH2CH2- OH and then reduced by KBH4 to give the bis(ethylenedioxy) pregnanediol I, which reacted with MeMgBr to give pregnenedione II, after hydrolysis. The 2,4-dibromo deriv. of II was debrominated in DMF contg. Li2- CO3 and LiBr to give the title compd. III.

Also in the Knowledge Center

Related Content

Regulatory Affairs

Hovione has filings with every world health authority that has a DMF system for APIs including FDA EDQM PMDA,MHRA, HPRA, Infarmed among others.

Page
Read more

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more

Health, Safety, Environment and Energy (HSEEn)

Zero accidents is our main goal

Page
Read more